Prelude Capital Management’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,528
| Closed | -$1.13M | – | 1450 |
|
|
2025
Q4 | $1.13M | Buy |
6,528
+4,243
| +186% | +$697K | 0.08% | 271 |
|
|
2025
Q3 | $437K | Buy |
+2,285
| New | +$421K | 0.03% | 542 |
|
|
2023
Q2 | – | Sell |
-970
| Closed | -$259K | – | 1272 |
|
|
2023
Q1 | $259K | Buy |
+970
| New | +$279K | 0.02% | 716 |
|
|
2022
Q3 | – | Sell |
-2,033
| Closed | -$568K | – | 1795 |
|
|
2022
Q2 | $568K | Buy |
2,033
+1,368
| +206% | +$413K | 0.02% | 752 |
|
|
2022
Q1 | $222K | Buy |
+665
| New | +$205K | 0.01% | 1213 |
|
|
2021
Q2 | – | Sell |
-905
| Closed | -$212K | – | 1842 |
|
|
2021
Q1 | $212K | Buy |
+905
| New | +$202K | 0.01% | 1308 |
|
|
2020
Q4 | – | Sell |
-543
| Closed | -$99K | – | 1716 |
|
|
2020
Q3 | $99K | Buy |
543
+363
| +202% | +$66K | ﹤0.01% | 915 |
|
|
2020
Q2 | $32K | Sell |
180
-342
| -66% | -$58.2K | ﹤0.01% | 1275 |
|
|
2020
Q1 | $73K | Sell |
522
-1,882
| -78% | -$252K | ﹤0.01% | 676 |
|
|
2019
Q4 | $326K | Buy |
2,404
+1,851
| +335% | +$233K | 0.01% | 693 |
|
|
2019
Q3 | $61K | Sell |
553
-749
| -58% | -$97K | ﹤0.01% | 1107 |
|
|
2019
Q2 | $186K | Buy |
1,302
+222
| +21% | +$30.4K | 0.01% | 758 |
|
|
2019
Q1 | $153K | Sell |
1,080
-180
| -14% | -$24.3K | 0.01% | 794 |
|
|
2018
Q4 | $146K | Sell |
1,260
-22
| -2% | -$2.88K | 0.01% | 828 |
|
|
2018
Q3 | $191K | Buy |
1,282
+919
| +253% | +$117K | 0.01% | 772 |
|
|
2018
Q2 | $36K | Sell |
363
-1,072
| -75% | -$93.4K | ﹤0.01% | 1211 |
|
|
2018
Q1 | $116K | Buy |
1,435
+735
| +105% | +$59.1K | 0.01% | 831 |
|
|
2017
Q4 | $54K | Buy |
+700
| New | +$50.5K | ﹤0.01% | 922 |
|
|
2017
Q3 | – | Sell |
-500
| Closed | -$35K | – | 1804 |
|
|
2017
Q2 | $35K | Sell |
500
-1,870
| -79% | -$115K | ﹤0.01% | 1109 |
|
|
2017
Q1 | $108K | Sell |
2,370
-3,680
| -61% | -$193K | 0.01% | 763 |
|
|
2016
Q4 | $328K | Buy |
6,050
+198
| +3% | +$10.8K | 0.04% | 414 |
|
|
2016
Q3 | $341K | Buy |
5,852
+399
| +7% | +$22K | 0.04% | 395 |
|
|
2016
Q2 | $272K | Buy |
5,453
+2,453
| +82% | +$131K | 0.04% | 414 |
|
|
2016
Q1 | $193K | Sell |
3,000
-5,800
| -66% | -$344K | 0.03% | 568 |
|
|
2015
Q4 | $529K | Buy |
8,800
+6,200
| +238% | +$391K | 0.08% | 266 |
|
|
2015
Q3 | $179K | Sell |
2,600
-800
| -24% | -$59.3K | 0.03% | 641 |
|
|
2015
Q2 | $239K | Sell |
3,400
-200
| -6% | -$13.4K | 0.03% | 521 |
|
|
2015
Q1 | $242K | Sell |
3,600
-1,400
| -28% | -$80.9K | 0.03% | 582 |
|
|
2014
Q4 | $268K | Sell |
5,000
-1,000
| -17% | -$48.4K | 0.04% | 536 |
|
|
2014
Q3 | $254K | Buy |
6,000
+300
| +5% | +$13.3K | 0.04% | 614 |
|
|
2014
Q2 | $254K | Hold |
5,700
| – | – | 0.03% | 645 |
|
|
2014
Q1 | $214K | Buy |
5,700
+4,600
| +418% | +$170K | 0.03% | 708 |
|
|
2013
Q4 | $38K | Sell |
1,100
-2,300
| -68% | -$77.5K | 0.01% | 1128 |
|
|
2013
Q3 | $121K | Buy |
+3,400
| New | +$125K | 0.02% | 716 |
|
Other funds holding MOH
VPM
VCM
Prelude Capital Management's MOH Position: Q1 2026 in Review
Prelude Capital Management sold out of Molina Healthcare (MOH) in Q1 2026, closing a stake of 6,528 shares — an estimated $1.13M sold.
Prelude Capital Management first reported a position in MOH in Q3 2013 and held it in 34 quarters. The position peaked at $1.13M in Q4 2025. 524 funds tracked by Wall St. Rank hold MOH as of Q1 2026.
- Prelude Capital Management reported no remaining Molina Healthcare position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 6,528 Molina Healthcare shares in Q1 2026, an estimated $1.13M.
- Prelude Capital Management first reported a position in Molina Healthcare in Q3 2013 and held it in 34 quarters.
- Prelude Capital Management's Molina Healthcare position peaked at $1.13M in Q4 2025.
- 524 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.